Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) – 2021 to 2026

$3,850.00$5,850.00

Published on: March 23, 2021
Clear
SKU: GMS-3022 Category:

OVERVIEW

Amid the COVID-19 outbreak, the market for lung cancer surgery is expected to hit USD 35.21 billion by 2026, increasing from 2021 to 2026 at a CAGR of 5.85%. The major factors driving this market’s growth are the growing incidence and prevalence of lung cancer, rapid growth in the aging population, and rising global healthcare spending. In the following report, the impact of the COVID-19 outbreak on the industry will be fully assessed. The reports also compares the markets of Pre COVID-19 and Post COVID-19.

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 1

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 2

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 3

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 4

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 5

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 6

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 7

Lung Cancer Surgery Market by Device (Surgical, Monitoring, Endoscopic Instrument), Procedure (Thoracotomy, Minimally Invasive) - 2021 to 2026 8

TABLE OF CONTENT

1 Global Lung Cancer Surgery Market
1.1 Study Objectives
1.2 Market Definition
1.3 Study Scope
1.3.1 Markets Covered
1.3.2 Geographic Scope

2 RESEARCH METHODOLOGY
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.1.2.2 Key Industry Insights
2.1.2.3 Breakdown of Primaries
2.2 Market Size Estimation
2.2.1 Bottom-Up Approach
2.2.2 Top-Down Approach
2.3 Market Breakdown and Data Triangulation
2.4 Research Assumptions

3 Global Lung Cancer Surgery Market – Executive Summary
3.1 Market Revenue, Market Size and Key Trends by Company
3.2 Key Trends by type of Application
3.3 Key Trends segmented by Geography

4 Global Lung Cancer Surgery Market – Comparative Analysis
4.1 Product Benchmarking – Top 10 companies
4.2 Top 5 Financials Analysis
4.3 Market Value split by Top 10 companies
4.4 Patent Analysis – Top 10 companies
4.5 Pricing Analysis

5 Global Lung Cancer Surgery Market – Industry Market Entry Scenario
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing business index
5.3 Case studies of successful ventures
5.4 Customer Analysis – Top 10 companies

6 Global Lung Cancer Surgery Market – Market Forces
6.1 Introduction
6.2 Market Dynamics
6.2.1 Drivers
6.2.2 Opportunities
6.2.3 Challenges
6.3 Porters Analysis of Market
6.3.1 Bargaining power of suppliers
6.3.2 Bargaining powers of customers
6.3.3 Threat of new entrants
6.3.4 Rivalry among existing players
6.3.5 Threat of substitutes

7 Global Lung Cancer Surgery Market – Strategic Analysis
7.1 Value Chain analysis
7.2 Product Life Cycle
7.3 Supplier and distributor analysis (Market share and product dealing strategies)

8 Global Lung Cancer Surgery Market – By Surgical Devices (Market Size – & million/billion)
8.1 Surgical Instruments
8.2 Hand Instruments
8.3 Monitoring and Visualizing Systems
8.4 Endosurgical Equipment

9 Global Lung Cancer Surgery Market – By Surgical Procedures
9.1 Thoracotomy
9.2 Sleeve Resection
9.3 Segmentectomy
9.4 Lobectomy
9.5 Pneumonectomy
9.6 Minimally Invasive Surgeries

10 Global Lung Cancer Surgery Market – By Geography (Market Size – & million/billion)
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 Europe
10.3.1 U.K
10.3.2 Germany
10.3.3 Italy
10.3.4 France
10.3.5 Spain
10.3.6 Rest of Europe
10.4 Asia-Pacific
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 South Korea
10.4.5 Rest of APAC
10.5 Rest of the World
10.5.1 South America
10.5.2 Middle East
10.5.3 Africa

11 Global Lung Cancer Surgery Market – Entropy
11.1 New product launches
11.2 M&A’s, collaborations, JVs and partnerships

12 Global Lung Cancer Surgery Market Company Profile (Key Players)
12.1 Market Share, Company Revenue, Products, M&A, Developments
12.2 Teleflex Incorporated
12.3 Intuitive Surgical Inc.
12.4 Olympus Corporation
12.5 Ethicon US, LLC
12.6 Accuray Incorporated
12.7 Angiodynamics Inc.
12.8 Karl Storz GmbH
12.9 Ackermann Instrumente GmbH
12.10 Scanlan International, Inc.
12.11 Trokamed GmbH
12.12 Company 11 & more

13 Global Lung Cancer Surgery Market – Appendix
13.1 Sources
13.2 Abbreviations